Weight-loss injections like Ozempic, Wegovy, and Mounjaro are gaining popularity in the UAE, with many residents viewing them as a quick fix for shedding pounds. However, UAE doctors emphasize that these medications are not a cosmetic shortcut and are not suitable for everyone. Dr. Ali Aldibbiat, a diabetes and endocrinology consultant, explains that these drugs were originally developed to treat diabetes and belong to a class of hormones that regulate blood sugar and metabolism. While they were initially used for type 2 diabetes, researchers discovered their potential for weight reduction. Dr. Aldibbiat clarifies that these medications should not be seen as a magic solution for weight loss but rather as a helpful tool in a comprehensive weight-loss journey when used properly and under medical supervision.
Eligibility for these injections depends on medical criteria. According to Dr. Aldibbiat, individuals with a Body Mass Index (BMI) of 27 or higher, coupled with weight-related conditions like high blood pressure, high cholesterol, fatty liver, or joint problems, are typically prescribed these medications for weight management. Those with a BMI of 30 or above may qualify even without other health issues. When prescribed for diabetes, doctors also consider blood sugar control and potential heart or kidney risks.
The demand for these injections has surged significantly in the past year, with a notable increase in requests from younger, non-diabetic individuals seeking cosmetic weight loss. Dr. Brijesh Bharadwaj, an internal medicine specialist, attributes this rise to social media, where these medications are often promoted as magical drugs with quick results, sometimes without disclosing potential risks. However, doctors emphasize that injections alone are insufficient for weight loss and that a healthy lifestyle, including diet and physical activity, is crucial.
Stopping the medication abruptly is generally not harmful, but weight regain is common. Dr. Bharadwaj advises that patients must ensure adequate protein and vitamin intake when their appetite significantly decreases to avoid nutritional deficiencies. These medications are not suitable for everyone and should be avoided by individuals with a history of pancreatitis or a rare thyroid cancer called medullary thyroid carcinoma. Pregnant women, those trying to conceive, and breastfeeding mothers are also advised against using them.
Pharmacists stress the importance of caution and awareness. Ravi Sharma, chief pharmacy officer at Burjeel Holdings, clarifies that these medications are long-term metabolic therapies that work best alongside lifestyle modifications and medical monitoring. They are prescription-only drugs that must be taken under physician supervision. As the demand for these injections grows, experts reiterate that they are medical treatments and not magic shots, emphasizing the need for proper usage and medical guidance.
